A head-to-head comparison of Consensys Diligence and Immunefi — pricing, the features that actually differ, and which one fits which use case.
Ethereum-native audit team from the company behind MetaMask and Infura
The largest bug bounty marketplace connecting protocols with whitehat hackers
These are the 5 capabilities where the two tools genuinely diverge — the rest of their feature sets overlap.
| Capability | Consensys Diligence | Immunefi |
|---|---|---|
| Manual Audit | Yes | No |
| Automated Scanning | Yes | No |
| Continuous Monitoring | No | Yes |
| Formal Verification | Yes | No |
| Bug Bounty Management | No | Yes |
| Feature | Consensys Diligence | Immunefi |
|---|---|---|
| Manual Audit | ✓ | ✗ |
| Automated Scanning | ✓ | ✗ |
| Continuous Monitoring | ✗ | ✓ |
| Upgrade Management | ✗ | ✗ |
| Multi Sig Governance | ✗ | ✗ |
| Public Reports | ✓ | ✓ |
| Emergency Response | ✓ | ✓ |
| Contract Library | ✗ | ✗ |
| Formal Verification | ✓ | ✗ |
| Bug Bounty Management | ✗ | ✓ |
Pricing models differ substantially between these two.
Consensys Diligence
Custom
Immunefi
Custom
Watch out: Ethereum/EVM-focused, not multi-ecosystem.
Watch out: Reactive — a bug must be found and reported.
Consensys Diligence edges ahead on our editorial score (4.7/5), but these tools aren’t straight substitutes. Pick Consensys Diligence when first-party ethereum pedigree via consensys matters most to your workflow; pick Immunefi when largest bug bounty marketplace in web3 is the priority. The deciding factor is usually the trade-off you can least afford — Consensys Diligence means accepting that ethereum/evm-focused, not multi-ecosystem, while Immunefi means reactive — a bug must be found and reported.
Consensys Diligence carries the higher editorial rating (4.7/5 vs 4.6/5), but they solve different problems. Consensys Diligence is the stronger pick when you need first-party ethereum pedigree via consensys. Immunefi wins when largest bug bounty marketplace in web3.
Both are priced on request — expect quote-based pricing rather than public tiers.
Consensys Diligence's main limitation is that ethereum/evm-focused, not multi-ecosystem. For Immunefi, reactive — a bug must be found and reported. Weigh these against how you actually plan to use the tool.
In most cases yes — many teams run both, using each where it's strongest. Since Consensys Diligence leads on first-party ethereum pedigree via consensys and Immunefi on largest bug bounty marketplace in web3, the two are often complementary rather than mutually exclusive.